Escalating-Dose HLA-mismatched DLI Is Safe for the Treatment of Leukaemia Relapse Following Alemtuzumab-Based Myeloablative Allo-SCT

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2013.69
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical and Biological Predictors of Outcome Following Relapse of CML Post-Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2014English

Occult Autologous Haematopoietic Regeneration Without Disease Relapse Following Myeloablative Allogeneic Haematopoietic SCT for Lymphomas

Bone Marrow Transplantation
TransplantationHematology
2009English

Escalating Doses of Donor Lymphocytes for Incipient Graft Rejection Following SCT for Thalassemia

Bone Marrow Transplantation
TransplantationHematology
2009English

Outpatient Myeloablative Allo-Sct: A Comprehensive Approach Yields Decreased Hospital Utilization and Low TRM

Bone Marrow Transplantation
TransplantationHematology
2009English

Enteral Nutrition: A First Option for Nutritional Support of Children Following Allo-Sct?

Bone Marrow Transplantation
TransplantationHematology
2012English

The Impact of Graft Composition on Clinical Outcomes in Unmanipulated HLA-mismatched/haploidentical Hematopoietic SCT

Bone Marrow Transplantation
TransplantationHematology
2008English

HLA-identical Haematopoietic Stem Cell Transplantation for Acute Leukaemia in Children: Less Relapse With Higher Biologically Effective Dose of TBI

Bone Marrow Transplantation
TransplantationHematology
2007English

Full-Dose 90Y Ibritumomab Tiuxetan Therapy Is Safe in Patients With Prior Myeloablative Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2005English

Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML

Bone Marrow Transplantation
TransplantationHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy